Pfizer
PFE
2,378 hedge funds and large institutions have $176B invested in Pfizer in 2019 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 926 increasing their positions, 1,102 reducing their positions, and 75 closing their positions.
29% more call options, than puts
Call options by funds: $1.74B | Put options by funds: $1.35B
23% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 75
2% more capital invested
Capital invested by funds: $173B → $176B (+$2.73B)
1% less funds holding
Funds holding: 2,392 → 2,378 (-14)
0.68% less ownership
Funds ownership: 77.53% → 76.85% (-0.68%)
1% less funds holding in top 10
Funds holding in top 10: 202 → 199 (-3)
16% less repeat investments, than reductions
Existing positions increased: 926 | Existing positions reduced: 1,102
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.49B |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.45B |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$572M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$322M |
| 5 |
N
Natixis
Paris,
France
|
+$250M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$829M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$619M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$573M |
| 4 |
Goldman Sachs
New York
|
-$536M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$306M |
PFE Hedge Fund Activity: Q2 2019 in Review
2,378 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2019, worth a combined $176B — up 1.6% from $173B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new PFE positions and 75 closed out — a net gain of 17 holders — while 926 added to existing stakes and 1,102 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $2.49B. The largest seller was BlackRock, cutting an estimated $829M.
- 2,378 institutional investors held Pfizer (PFE) as of Q2 2019, down from 2,392 in Q1 2019.
- Funds reported $176B of Pfizer stock for Q2 2019, up 1.6% quarter-over-quarter.
- 92 funds opened new Pfizer positions in Q2 2019 and 75 closed out, a net change of +17 holders.
- The largest Pfizer buyer in Q2 2019 was Wellington Management Group, an estimated $2.49B added.
- The largest Pfizer seller in Q2 2019 was BlackRock, an estimated $829M sold.
Based on aggregated 13F filings for Q2 2019.